Granahan Investment Management - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 134 filers reported holding SAGE THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2016$14,555,000
+0.8%
316,065
-34.1%
0.48%
-9.3%
Q2 2016$14,441,000
-7.5%
479,275
-1.6%
0.53%
-7.4%
Q1 2016$15,613,000
-2.6%
486,985
+77.2%
0.57%
+3.1%
Q4 2015$16,026,000
+21.7%
274,885
-11.7%
0.55%
+35.0%
Q3 2015$13,173,000
-34.3%
311,265
+13.3%
0.41%
-28.2%
Q2 2015$20,051,000
+167.6%
274,665
+84.1%
0.57%
+165.4%
Q1 2015$7,492,000149,1560.21%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders